India’s pharma rise has been rooted in large-scale, low-cost manufacturing, especially generics, APIs and vaccines. The sector is now the eleventh-largest globally by value, in spite of generics being ...

After 80 years of fruitless struggle by human mathematicians, a major geometry conjecture has at last been solved—via a straightforward query to a chatbot. “No previous AI-generated proof has come ...

The claim that Java is ‘dead’ has been made so repeatedly that it has become a cliche. In 2026, it is still one of the most popular programming languages. It is still one of the most popular languages ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

WASHINGTON — Our investigation, Tainted Trust: Inside the Global Medicine Pipeline, reveals how the drugs taken by millions of Americans trace back to factories in India, a system plagued by weak ...

Some three months after merging, Mallinckrodt and Endo have taken the next step toward their joint future by spinning off their sterile injectables and generics businesses. With the transformation ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Passing the AWS Certified Solutions Architect Associate exam is one of the most powerful ways to ...